George D. Yancopoulos

E579607

George D. Yancopoulos is an American biomedical scientist and biotechnology executive best known as the longtime scientific leader and co-founder of Regeneron Pharmaceuticals, where he has driven the development of multiple blockbuster biologic drugs.

All labels observed (1)

Label Occurrences
George D. Yancopoulos canonical 2

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf biomedical scientist
biotechnology executive
human
academicDegree Bachelor’s degree from Columbia University
MD from Columbia University College of Physicians and Surgeons
PhD from Columbia University
awardReceived recognition for contributions to biotechnology industry
citizenship United States of America
coFounded Regeneron Pharmaceuticals NERFINISHED
doctoralAdvisor Frederick Alt NERFINISHED
educatedAt Columbia University
Columbia University College of Physicians and Surgeons NERFINISHED
employer Regeneron Pharmaceuticals NERFINISHED
fieldOfWork biomedicine
biotechnology
immunology
molecular biology
hasEthnicGroup Greek American NERFINISHED
hasRole co-founder of Regeneron Pharmaceuticals
scientific leader of Regeneron Pharmaceuticals
industry biotechnology
pharmaceutical industry
knownFor Regeneron Pharmaceuticals NERFINISHED
languageSpoken English
memberOf American scientific community
name George D. Yancopoulos NERFINISHED
nationality United States of America
notableAchievement helped establish Regeneron as a major biotechnology company NERFINISHED
led discovery and development of multiple blockbuster biologic drugs at Regeneron
notableWork Regeneron’s COVID‑19 antibody cocktail (REGEN‑COV / casirivimab and imdevimab) NERFINISHED
Regeneron’s VelocImmune platform NERFINISHED
Regeneron’s VelociGene platform NERFINISHED
Regeneron’s VelociMouse technology NERFINISHED
Regeneron’s VelociSuite antibody discovery technologies NERFINISHED
development of Dupixent (dupilumab)
development of Eylea (aflibercept)
development of Kevzara (sarilumab)
development of Praluent (alirocumab)
development of monoclonal antibody therapeutics at Regeneron
positionHeld Chief Scientific Officer
Chief Scientific Officer of Regeneron Pharmaceuticals
President and Chief Scientific Officer of Regeneron Pharmaceuticals
researchInterest cytokines
immune system signaling pathways
therapeutic antibodies
workLocation New York City
Tarrytown, New York NERFINISHED

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Regeneron Pharmaceuticals foundedBy George D. Yancopoulos
Regeneron Pharmaceuticals hasKeyPerson George D. Yancopoulos